Warfarin Sodium
Product Images NDC 70934-911

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70934-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 911 30 Master Bottle Label Approval Rev A 10 21)

Label (70934 911 30 Master Bottle Label Approval   Rev A 10 21)
Label for Warfarin Sodium Tablets USP 2.5 mg in a 30-tablet package from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes the NDC number 70934-911-30 and storage instructions to keep the medication at 20-25°C with excursions permitted between 15-30°C. It also states that the product is a prescription drug, highly potent anticoagulant, and advises consulting the dosage insert before use.*
FDA Label Image

474ff828-figure-01 (Warfarin Sodium Tablets Usp 1)

474ff828-figure-01 (Warfarin Sodium Tablets Usp 1)
Chemical structure diagram of warfarin sodium showing two benzene rings and the core molecular framework, consistent with the active ingredient in Warfarin Sodium by Denton Pharma, Inc. DBA Northwind Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.